Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice

Summary: Preterm birth may result in adverse health outcomes. Very preterm infants typically exhibit postnatal growth restriction, metabolic disturbances, and exaggerated inflammatory responses. We investigated the differences in the meconium microbiota composition between very preterm (<32 weeks...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Henni Hiltunen, Hila Hanani, Raakel Luoto, Sondra Turjeman, Oren Ziv, Erika Isolauri, Seppo Salminen, Omry Koren, Samuli Rautava
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/1683e7a22fca4693b4f21ca6621f6cc1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1683e7a22fca4693b4f21ca6621f6cc1
record_format dspace
spelling oai:doaj.org-article:1683e7a22fca4693b4f21ca6621f6cc12021-11-18T04:52:14ZPreterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice2666-379110.1016/j.xcrm.2021.100447https://doaj.org/article/1683e7a22fca4693b4f21ca6621f6cc12021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666379121003153https://doaj.org/toc/2666-3791Summary: Preterm birth may result in adverse health outcomes. Very preterm infants typically exhibit postnatal growth restriction, metabolic disturbances, and exaggerated inflammatory responses. We investigated the differences in the meconium microbiota composition between very preterm (<32 weeks), moderately preterm (32–37 weeks), and term (>37 weeks) human neonates by 16S rRNA gene sequencing. Human meconium microbiota transplants to germ-free mice were conducted to investigate whether the meconium microbiota is causally related to the preterm infant phenotype in an experimental model. Our results indicate that very preterm birth is associated with a distinct meconium microbiota composition. Fecal microbiota transplant of very preterm infant meconium results in impaired growth, altered intestinal immune function, and metabolic parameters as compared to term infant meconium transplants in germ-free mice. This finding suggests that measures aiming to minimize the long-term adverse consequences of very preterm birth should be commenced during pregnancy or directly after birth.Henni HiltunenHila HananiRaakel LuotoSondra TurjemanOren ZivErika IsolauriSeppo SalminenOmry KorenSamuli RautavaElsevierarticlegerm-free micepreterm infantgut microbiotafecal microbiota transplantgrowthinflammationMedicine (General)R5-920ENCell Reports Medicine, Vol 2, Iss 11, Pp 100447- (2021)
institution DOAJ
collection DOAJ
language EN
topic germ-free mice
preterm infant
gut microbiota
fecal microbiota transplant
growth
inflammation
Medicine (General)
R5-920
spellingShingle germ-free mice
preterm infant
gut microbiota
fecal microbiota transplant
growth
inflammation
Medicine (General)
R5-920
Henni Hiltunen
Hila Hanani
Raakel Luoto
Sondra Turjeman
Oren Ziv
Erika Isolauri
Seppo Salminen
Omry Koren
Samuli Rautava
Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
description Summary: Preterm birth may result in adverse health outcomes. Very preterm infants typically exhibit postnatal growth restriction, metabolic disturbances, and exaggerated inflammatory responses. We investigated the differences in the meconium microbiota composition between very preterm (<32 weeks), moderately preterm (32–37 weeks), and term (>37 weeks) human neonates by 16S rRNA gene sequencing. Human meconium microbiota transplants to germ-free mice were conducted to investigate whether the meconium microbiota is causally related to the preterm infant phenotype in an experimental model. Our results indicate that very preterm birth is associated with a distinct meconium microbiota composition. Fecal microbiota transplant of very preterm infant meconium results in impaired growth, altered intestinal immune function, and metabolic parameters as compared to term infant meconium transplants in germ-free mice. This finding suggests that measures aiming to minimize the long-term adverse consequences of very preterm birth should be commenced during pregnancy or directly after birth.
format article
author Henni Hiltunen
Hila Hanani
Raakel Luoto
Sondra Turjeman
Oren Ziv
Erika Isolauri
Seppo Salminen
Omry Koren
Samuli Rautava
author_facet Henni Hiltunen
Hila Hanani
Raakel Luoto
Sondra Turjeman
Oren Ziv
Erika Isolauri
Seppo Salminen
Omry Koren
Samuli Rautava
author_sort Henni Hiltunen
title Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
title_short Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
title_full Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
title_fullStr Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
title_full_unstemmed Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
title_sort preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
publisher Elsevier
publishDate 2021
url https://doaj.org/article/1683e7a22fca4693b4f21ca6621f6cc1
work_keys_str_mv AT hennihiltunen preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT hilahanani preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT raakelluoto preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT sondraturjeman preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT orenziv preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT erikaisolauri preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT sepposalminen preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT omrykoren preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
AT samulirautava preterminfantmeconiummicrobiotatransplantinducesgrowthfailureinflammatoryactivationandmetabolicdisturbancesingermfreemice
_version_ 1718424958937333760